-
Mashup Score: 4VANFLYTA® is Now Approved in Canada Specifically for Adult Patients with Newly Diagnosed FLT3-ITD Positive AML - 6 day(s) ago
/CNW/ – Daiichi Sankyo’s (TSE: 4568) VANFLYTA (quizartinib) has been approved by Health Canada for use in combination with standard cytarabine and…
Source: www.newswire.caCategories: General Medicine NewsTweet
-
Mashup Score: 1
/CNW/ – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced Health Canada has granted Marketing Authorization for PrCASGEVY® (exagamglogene…
Source: www.newswire.caCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Zynext Ventures Invests in neuro42, A Company Developing Portable MRI Systems for Neuroimaging and Interventions - 10 month(s) ago
/CNW/ — Zynext Ventures USA LLC (Zynext Ventures), the Venture Capital (VC) arm of Zydus Lifesciences (Zydus), committed to advancing disruptive breakthroughs…
Source: www.newswire.caCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 6
/CNW/ – Eli Lilly Canada Inc. announced today that Health Canada authorized Ebglyss™ (lebrikizumab), a targeted IL-13 inhibitor, for the treatment of…
Source: www.newswire.caCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 18LG UNVEILS 'MYVIEW' 4K SMART MONITOR AT CES 2024 - 1 year(s) ago
/CNW/ – LG Electronics’ (LG) new lineup of ‘LG MyView’ smart monitors will be revealed at CES 2024. Designed for productivity and entertainment, each monitor…
Source: www.newswire.caCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 1The Body Shop Becomes First Global Beauty Brand to Achieve 100% Vegan Product Formulations Certified by The Vegan Society - 1 year(s) ago
/CNW/ – Today, The Body Shop announces its 100% vegan achievement, making it the world’s first global beauty brand* to offer 100% vegan product formulations…
Source: www.newswire.caCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 6
/CNW/ – Mitsubishi Tanabe Pharma Canada (MTP-CA) a subsidiary of Mitsubishi Tanabe Pharma America, Inc. (MTPA), announced today that RADICAVA® Oral Suspension…
Source: www.newswire.caCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 2Innovative digital therapeutics program shows a reduction in hospitalizations and costs for heart failure patients - 2 year(s) ago
/CNW/ – The CONTINUUM program, a remote patient monitoring and digital therapeutics project led by The Centre hospitalier de l’Université de Montréal (CHUM),…
Source: www.newswire.caCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 16
/CNW/ – Heart & Stroke celebrates the Ontario government’s commitment to opt into the federal government’s excise tax on vaping, as outlined in their fall…
Source: www.newswire.caCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 6
/CNW/ — BlackBerry Limited (NYSE: BB; TSX: BB) today announced its new Generative AI powered assistant for Security Operations Center (SOC) teams. The…
Source: www.newswire.caCategories: Healthcare Professionals, Latest HeadlinesTweet
🚨News🚨 @GovCanHealth has approved quizartinib + standard cytarabine/anthracycline induction and cytarabine consolidation followed by quizartinib maintenance for ND FLT3-ITD+ AML, based on QuANTUM-First trial results. Read more: https://t.co/F7KecfXOvV #AMLsm #leusm #MedNews https://t.co/ubouicKe29